Literature DB >> 27091414

Antidepressants and Driving in Older Adults: A Systematic Review.

Duncan H Cameron1, Mark J Rapoport1.   

Abstract

With an increasing number of older drivers who are prescribed antidepressants, the potential consequences of antidepressant use on driving skills in an aging population are becoming a pressing issue. We conducted a systematic review using MEDLINE, targeting articles specifically pertaining to antidepressants and driving in a population or subgroup of older adults (≥ 55 years of age). The search yielded 267 references, nine of which pertained to the effects of antidepressants on driving in older adults. The single experimental study found imipramine to have detrimental effects on highway driving, whereas nefazodone did not. Seven of eight population-based studies reported a significant increased risk of involvement in a collision associated with antidepressant use. Although the studies indicated a negative effect of antidepressants on driving, the epidemiological designs cannot exclude the possibility that the underlying illness, generally major depression, is the culprit.

Entities:  

Keywords:  accidents de la circulation; aging; antidepressive agents; antidépresseuses; aînés; collisions automobiles; conduite; driving; motor vehicle collisions; seniors; traffic; traffic accidents; vieillissment

Mesh:

Substances:

Year:  2016        PMID: 27091414     DOI: 10.1017/S0714980816000064

Source DB:  PubMed          Journal:  Can J Aging        ISSN: 0714-9808


  2 in total

1.  Scared to Trust? - Predicting Trust in Highly Automated Driving by Depressiveness, Negative Self-Evaluations and State Anxiety.

Authors:  Johannes Kraus; David Scholz; Eva-Maria Messner; Matthias Messner; Martin Baumann
Journal:  Front Psychol       Date:  2020-01-23

2.  Use of psychotropic medication and risk of road traffic crashes: a registry-based case-control study in Denmark, 1996-2018.

Authors:  Anne Vingaard Olesen; Tanja Kidholm Osmann Madsen; Harry Lahrmann; Jimmi Nielsen
Journal:  Psychopharmacology (Berl)       Date:  2022-04-23       Impact factor: 4.415

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.